Showing results (471-480 of 1,998) with videos related to

Sort By:
Pageof 200
Endocrine, Metabolic & Immune Disorders Drug Targets|September 4, 2026
Signaling Pathways and Medicinal Properties of Quercitrin: A ReviewWenchen Yang, Lei Wen, Yee Xing You, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 4, 2026
Charting the Therapeutic Landscape of Naringin in Osteopathic and Metabolic MedicineZilan Zhong, Pingjin Xie, Yifei Wang, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 7, 2026
Age and Gender on the Efficacy of Metabolic Surgery in Patients with Obesity and Type 2 DiabetesBo Ma, Yangfan Dong, Tao Li, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 24, 2026
Recent Advancements in Mastitis Management: Challenges and Opportunities-A Systematic ReviewSwaroop Kumar Pandey, Swati Tripathi, Anuja Mishra
Endocrine, Metabolic & Immune Disorders Drug Targets|September 8, 2026
The Food Paradox: Converting Foreign Matter into SelfPaolo Riccio, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|September 8, 2026
Current Insights into the Phytochemistry, Traditional, and Biological Importance of Matricaria pubescens (Desf.) SchultzSmail Amtaghri, Corinne Raïssa Ngnameko, Motlalepula G Matsabisa
Endocrine, Metabolic & Immune Disorders Drug Targets|September 15, 2026
Changes in Biochemical Parameters and Their Correlation with Disease Severity in Patients with Metabolic Associated Fatty Liver Disease (MAFLD): A Cross-sectional StudyYuexia Zhang, Yanping Feng, Conglei You, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 5, 2026
Identification of Senescence- and Inflammation-Related Genes and Immune Microenvironment Characterization in Intracranial AneurysmsXiaoyan Li, Yingying Li, Le Zhang, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 4, 2022
Trimethylamine N-Oxide as a Potential Risk Factor for Non-communicable Diseases: A Systematic ReviewZahra Hoseini-Tavassol, Hanieh-Sadat Ejtahed, Bagher Larijani, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 5, 2015
Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with OsteoporosisIlker Tasci, Umut Safer, Umit Cintosun, et al.
Pageof 200